Nonviral Vectors for Cardiovascular Gene Delivery
The development of artificial gene delivery systems is an attractive problem. The delivery of nucleic acids to cells initially grew out of basic studies in molecular biology and virology but is now mainly considered within the context of gene therapy. This new therapeutic approach promises to be a singular advance in the treatment of both acquired and genetic diseases at the most fundamental levels of pathology. Nucleic acids are transferred into target cells to modify their genetic instructions so as to ameliorate or prevent a disease. Yet, the challenging problem of efficiently transferring and stably expressing transgenes in appropriate tissues needs to be solved in order for the great promise of gene therapy to be realized. One approach, viral vectors, is the basis of most preclinical studies and human clinical trials. Another approach is artificial gene delivery systems that go by a variety of descriptive names such as synthetic delivery systems, physical-chemical methods, and non-viral vectors, each of which emphasize different aspects of the approach. Table 1 lists the types of synthetic delivery methods that are under development.
KeywordsPermeability Toxicity Catheter Ischemia Albumin
Unable to display preview. Download preview PDF.
- Campra J, Reynolds T (1988) The hepatic circulation. In: Arias 1, WB J, Popper H, Schachter DShafritz D (eds) The liver: Biology and patholobiology. Raven Press, New York, pp 911–930Google Scholar
- Fraser R, et al (1980) High perfusion pressure damages the sieving ability of sinusoidal endothelium in rat livers. Brit J Exper Pathol 61: 222–228Google Scholar
- Gal D, Weir L, Leclerc G et al (1993) Direct myocardial transfection in two animal models. Evaluation of parameters affecting gene expression and per-cutaneous gene delivery. Lab Invest 68: 18–25Google Scholar
- Gidlof A, Lewis DH, Hammersen F (1988) The effect of prolonged total ischemia on the ultrastructure of human skeletal muscle capillaries. A morphometric analysis. Int J Microcir Clin Exp 7: 67–86Google Scholar
- Herweijer H, et al (2000) Retrograde coronary venous delivery of naked plasmid DNA. Mol Ther 1: S202Google Scholar
- Herweijer H, Zhang G, Subbotin VM et al (2001) Time course of gene expres- sion after plasmid DNA gene transfer to the liver. J Gen Med3: 280–291Google Scholar
- Isner JM, et al (1998) Treatment of thromboangiitis obliterans (Buerger’s disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg 28:964–973; discussion 973–965Google Scholar
- Langowski J, Kremer W, Kapp U(1992) Dynamic light scattering for study of solution conformation and dynamics of superhelical DNA. Methods Enzymol 211: 430–448Google Scholar
- Lewis DL, et al (2002) Efficient delivery of siRNA and inhibition of gene expression in post-natal mice. Nat Genet32: 107–108Google Scholar
- Nopanitaya W, Lamb JC, Grisham JW, Carson JL (1976) Effect of hepatic venous outflow obstruction on pores and fenestration in sinusoidal endothelium. Br J Exper Pathol 57: 604–609Google Scholar
- Taylor AE, Granger DN (1984) Exchange of macromolecules across the microcirculation. In: Renkin EM, Michel CCGeiger SR (eds) Handbook of Physiology: The cardiovascular system. Microcirculation. Am Physiol Soc, Bethesda, pp 467–653Google Scholar
- Zhang G, Vargo D, Budker V et al (1997) Expression of naked plasmid DNA injected into the afferent and efferent vessels of rodent and dog livers. Hum. Gene Ther 8: 1763–1772Google Scholar